Description
Mejora del control glucémico junto con dieta y ejercicio
Laboratorio: Boehringer Ingelheim México
MABTHERA® 500 mg/50 mL es un medicamento de uso intravenoso que contiene Rituximab
ideal para laboratorios clínicos
PRINCIPIO ACTIVO: CIPROFLOXACINO 400 MG
KETOROLAC SUB 30MG 6TAB AMS LGEN CLORURO DE OXIBUTININA Mejora del control glucémico juntoSUSTANCIA: KETOROLACO TAB. SUBLINGUAL 30 MG. CAJA C 6 FABRICANTE: AMSA GENERICO
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
